Higher expression of CCL25 in AML cells is associated with a poorer prognosis for AML patients, indicating the significant relevance of the CCL25–CCR9 axis in AML tumorigenesis [23,24]. This evidence concerns the gene CCL25 and acute myeloid leukemia.